Source:http://linkedlifedata.com/resource/pubmed/id/19200721
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-2-23
|
pubmed:abstractText |
A series of potent and selective 3,4-diamino-1,2,5-thiadiazoles were prepared and found to show excellent binding affinities towards CXCR2 receptor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1464-3405
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1434-7
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists.
|
pubmed:affiliation |
Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|